final action
on 12 Mar 2024
Last Applicant/ Owned by
Serial Number
79367898 filed on 23rd Nov 2022
Registration Number
N/A
Correspondent Address
P. Jay Hines
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Scientific research in the fields of medicine and health; research and development in the pharmaceutical and biotechnology fields; biological, scientific, clinical and medical research and development, namely, new product development in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; drug discovery services; pharmaceutical drug develoRead More
Medical and healthcare services; medical examinations; medical analysis services relating to the treatment of patients in the fields of microbiome modulating therapeutics, microbiology, biotechnology, the human immune system, the human gut microbiome, gastrointestinal health, genetics, microorganisms, bacteria and cells; health assessment surveys being health assessment services; medical health assessment services; medical analysis services relating to the treatment of persons; medical care services relating to patient treatment; analysis of human tissues for medical treatment; genetic testing for medical purposes; DNA screening for medical purposes; medical and healthcare services relating to DNA, genetics and genetic testing; genetic testing for medical purposes and medical diagnostic testing, namely, sequencing of microbiome and DNA in humans; medical diagnostic testing and medical analysis services for the diagnosis of gastrointestinal diseases and disorders; analysis of human serum for medical treatment; analysis of human excreta for medical treatment; human serum donation services; donation of bodily fluids and human waste; donation of human excreta; behavioural analysis for medical purposes; psychological assessment services; providing online medical record services in the nature of providing medical record analysis via a website designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concerns; preparation of reports relating to medical matters being providing medical information to medical professionals and patients in the form of reports in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing health information via a website; medical services connected with microbiome modulating therapeutics or intestinal microbiota transfer; medical services relating to the removal, treatment and processing of human cells; consultancy, information and advisory services relating to all of the aforesaid services
Scientific research in the fields of medicine and health; research and development in the pharmaceutical and biotechnology fields; biological, scientific, clinical and medical research and development, namely, new product development in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; drug discovery services; pharmaceutical drug development services; research and development of vaccines and medicines; research and development of compounds for use in targeted pharmaceutical therapies; medical and scientific pharmacological research services; research relating to molecular sciences and biotechnology; research and development of new products in the field of microorganisms and cells; research and development of new products in the field of therapeutics; scientific and medical research services in the field of microbiome modulating therapeutics; research and development of pharmaceutical preparations for the treatment of gastrointestinal disorders and diseases; research and development of biological drug delivery platforms; biochemical research and analysis; bacteriological research and analysis; scientific analysis in the field of intestinal microbiology; scientific analysis of human excreta for medical research; microbiological testing for medical research purposes; biological analysis; new product research and development, scientific analysis and product quality evaluation services in connection with biotechnology, microorganisms, cells, pharmaceuticals, medicine, molecular sciences, bacteria, physiology, biology, genetics, genomics, microbiome, metabolomics, proteomics, glycomics, biochemistry, probiotics, prebiotics, nutraceutical supplements, health, wellness, physical well-being, mental well-being, exercise, weight planning, weight management, diet, nutrition and sleep; new product research and development, scientific analysis, and product quality evaluation services in connection with microbiology, genetics, the human immune system, the human gut microbiome and gastrointestinal health; DNA screening for scientific research purposes; testing of pharmaceuticals; product quality testing for the purpose of authentication and quality control; scientific testing in the fields of biotechnology and chemistry; development of biochemical reagents; laboratory research services relating to pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; pharmaceutical product evaluation, namely, conducting early evaluations in the field of new pharmaceuticals; pharmaceutical research and development for use in clinical trials; providing information about the results of clinical trials for pharmaceutical products; diagnostic and testing services in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; structural and functional analysis of genomes; pharmaceutical research, namely, services for assessing the efficiency of medical and veterinary drugs; veterinary research and drug development services; new product design and development; new product design services relating to the biotechnology industry; analysis of product development; pharmaceutical product evaluation; scientific research and analysis in the nature of preparation of reports in the field of biotechnology and gut health; scientific research and analysis in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; consulting services for others in the field of design, planning and implementation scientific research project management in the field of scientific research; scientific risk assessment being scientific research consulting; industrial analysis and research being scientific analysis and research in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; analysis of product design being product failure analysis services; design and development of software in the fields of microbiome modulating therapeutics, microbiology biotechnology, the human immune system, the human gut microbiome, gastrointestinal health, genetics, microorganisms, bacteria or cells; development and design of mobile applications in the fields of pharmaceuticals, therapeutics, microbiology or molecular sciences; software and scientific algorithm research in the fields of pharmaceuticals, therapeutics, microbiome modulating therapeutics, microbiology, biotechnology, the human immune system, the human gut microbiome, gastrointestinal health, genetics, microorganisms, bacteria or cells; information technology services for the pharmaceutical and healthcare industries being consultancy relating to information technology infrastructure; writing of computer programs for biotechnological applications; maintaining databases for use in the fields of pharmaceuticals, therapeutics, microbiology or molecular sciences being maintenance of database systems; online electronic data storage; technical data analysis being scientific data analysis in the fields of pharmaceuticals, therapeutics, microbiome modulating therapeutics, microbiology, biotechnology, the human immune system, the human gut microbiome, gastrointestinal health, genetics, microorganisms, bacteria and cells; rental of software in the fields of microbiome modulating therapeutics, microbiology, biotechnology, the human immune system, the human gut microbiome, gastrointestinal health, genetics, microorganisms, bacteria or cells for identifying abnormalities in the human body and assessing suitability for therapeutic treatment; hosting websites on the internet in the field of healthcare and wellness; consultancy, information and advisory services relating to all of the aforesaid services; none of aforesaid for music and music production goods/services
Production of podcasts; provision of education and entertainment via podcast, namely, providing podcasts in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; writing of podcasts for education and entertainment purposes; education services, namely, classes, seminars, and workshops in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; entertainment services, namely, providing video podcasts in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; arranging and conducting of lectures, seminars and workshops in the fields of the human gut microbiome, human genetics, the human immune system and gastrointestinal disorders; arranging, organizing and conducting educational events; providing recognition and incentives by the way of awards to demonstrate excellence in the fields of medical and scientific research, namely, hosting and arranging award ceremonies; publishing and publication services being electronic publishing in the nature of publication of text of others on the internet featuring medical and scientific research; publication of the text of others on the internet featuring results of clinical trials; consultancy, information and advisory services relating to all of the aforesaid services; none of aforesaid for music and music production goods/services
Downloadable electronic databases for use in the medical field; downloadable podcasts in the field of scientific and medical research; measuring, detecting, monitoring and controlling devices in the fields of biotechnology, microorganisms, pharmaceuticals or microbiome modulating therapeutics, namely, fluorometers, filling level detectors, electric oxygen monitors for environmental use, and electronic control systems for machines; wearable activity tracker devices for taking biological measurements; instruments for analysing physical data being downloadable software for analysing data from the human gut microbiome; downloadable publications in electronic form in the nature of newsletters and magazines in the fields of microbiology, biotechnology, microorganisms, pharmaceuticals and microbiome modulating therapeutics; scientific apparatus and instruments for measuring DNA, RNA, proteins and bacteria; apparatus and instruments for the recording, transmission and reproduction of data, sound and images; medical laboratory research instruments for analysing protein sequence; encoded identity cards; blank smart cards; smart card readers; electronically encoded identity bracelets in the nature of wristbands; structural parts and fittings for all the aforesaid goods; none of aforesaid for music and music production goods/services
Pharmaceutical, medical and veterinary preparations for the treatment of abnormalities in human genetics, the human immune system, the human gut microbiome and other gastrointestinal disorders and diseases; pharmaceutical, medical and veterinary preparations in the field of microbiome modulating therapeutic medicines; pharmaceutical preparations for use in targeted pharmaceutical therapies for the treatment of abnormalities in human genetics, the human immune system, the human gut microbiome and other gastrointestinal disorders and diseases; pharmaceutical preparations and products for the treatment of gastrointestinal disorders and diseases; biotechnological preparations for medical use, namely, pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; biological compounds for use in targeted pharmaceutical therapies for the treatment of abnormalities in the human immune system, the human gut microbiome, and other gastrointestinal disorders and diseases; proteins with diagnostic and therapeutic uses, namely, protein arrays for medical diagnostic purposes; chemical reagents for medical and veterinary purposes and enzyme preparations for medical or veterinary purposes; reagents and diagnostic preparations for use in testing for medical and veterinary purposes; drug delivery agents consisting of compounds that facilitate the delivery of a wide range of pharmaceutical preparations; intestinal microbiome pharmaceutical preparations; nutritive agents for processing living cells for medical use, namely, nutritive substances for microorganism cultures; reagents for use in biological processing for medical purposes being diagnostic reagents for medical use; solutions for medical use in the preservation of human excreta; preservatives for maintaining the viability of micro-organisms in cultures for medical purposes being nutritive substances for microorganism cultures; probiotic bacterial formulations for medical use; clinical medical reagents; diagnostic and testing preparations for medical purposes; diagnostic reagents and assay components, namely, medical diagnostic reagents and assays for testing body fluids; enzymes for medical purposes; yeast for intracellular production of recombinant proteins being biochemical preparations for medical purposes; yeast for pharmaceutical purposes; dietary supplements; food supplements; topical gels for medical and therapeutic use in the treatment of abnormalities in the human immune system, the human gut microbiome and other gastrointestinal disorders and diseases; intestinal microbiome medicinal preparations; pharmaceutical and therapeutic preparations for use in the treatment of abnormalities in the fields of microbiology, genetics, the human immune system, the human gut microbiome and gastrointestinal health; diagnostic preparations for clinical medical use in the fields of microbiology, genetics, the human immune system, the human gut microbiome and gastrointestinal health; medical bacterial preparations for use in connection with intestinal microbiota transfer; chemical reagent preparations for use in medicine; diagnostic biomarker reagents for in vitro or in vivo testing for medical use
Chemicals, reagents and chemical substances for medical research laboratory purposes; chemical additives for use in the manufacture of medicines and pharmaceuticals; diagnostic preparations and reagents for scientific or research use; enzymes for scientific purposes; chemicals, reagents and chemical substances for medical research laboratory purposes; proteins for use in industry and protein in raw material form for science, namely, for scientific research; diagnostic test kits for scientific or research use, comprised of buffer solutions, assays and reagents; enzyme preparations for the processing of excreta being enzymes for scientific and research purposes; enzyme preparations for the processing of waste matter being enzymes for scientific and research purposes; nutritive agents for processing living cells, namely nutritive substances for microorganism cultures other than for medical use; reagents for use in biological processing other than for medical purposes being reagents for scientific and research use; antimicrobial preservatives for pharmaceuticals; preservatives for use in the pharmaceutical industry; solutions for scientific use in the preservation of human excreta being chemicals for use in industry and science; preservatives for maintaining the viability of micro-organisms in cultures for scientific purposes being chemicals for use in science; enzyme stabilizers; chemical substances for stabilizing human waste, including faeces being chemicals for use in industry and science
No 79367898
No Service Mark
No HRF0022TUS
No
No
No
No
Yes
Yes
No
No
| Status Date | Action Taken |
|---|---|
| 12th Mar 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 12th Mar 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 12th Mar 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 01st Nov 2023 | REFUSAL PROCESSED BY IB |
| 11th Oct 2023 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 10th Oct 2023 | REFUSAL PROCESSED BY MPU |
| 14th Sep 2023 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 13th Sep 2023 | NON-FINAL ACTION WRITTEN |
| 06th Sep 2023 | ASSIGNED TO EXAMINER |
| 24th May 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
